AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21418785 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 25 mg twice weekly
Number of subjects: 549
Study 19263128 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on a laparoscopic simulator
Number of subjects: 0
Study 19263128 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 0
Study 17420365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral or intravitreal injection of 40 microg of gentamicin sulfate and 45 microg of clindamycin
Number of subjects: 346
Study 17420365 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution
Number of subjects: 346
Study 17420365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection
Number of subjects: 346
Study 17420365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral injection
Number of subjects: 346
Study 14633177 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction treatment with a daily dose of 5 MU of IFN‐alpha2b for 4 weeks, followed by 5 MU three times a week with ribavirin (1000‐1200 mg/day, according to weight) until completing 1 year of treatment.
Number of subjects: 614
Study 14633177 — intervention group
Group type: COMPARATOR
Intervention: Standard dose of IFN‐alpha2b of 3 MU three times per week for 48 weeks together with ribavirin (1000‐1200 mg/day, according to weight).
Number of subjects: 614
Study 14633177 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction treatment in patients with genotype 1 and elevated viral load (>2 x 10(6) copies/ml).
Number of subjects: 614
Study 14633177 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction treatment compared to standard treatment regarding dropouts and side effects.
Number of subjects: 614
Study 11042297 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 121
Study 11042297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 9364690 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP
Number of subjects: 4181
Study 9364690 — intervention group
Group type: COMPARATOR
Intervention: DTwP
Number of subjects: 4181
Study 1550038 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast treatment (three meals per day)
Number of subjects: 52
Study 1550038 — intervention group
Group type: COMPARATOR
Intervention: No-breakfast treatment (two meals per day)
Number of subjects: 52
Study 3993543 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (160 to 320 mg/day)
Number of subjects: 39
Study 3993543 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 to 200 mg/day)
Number of subjects: 39
Study 3993543 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 39
Study 31333187 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotherapy (kinesio taping)
Number of subjects: 50
Study 31333187 — intervention group
Group type: COMPARATOR
Intervention: Sham taping (control)
Number of subjects: 50
Study 29738358 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood pressure group
Number of subjects: 420
Study 29738358 — intervention group
Group type: COMPARATOR
Intervention: Normal blood pressure group
Number of subjects: 420
Study 27282119 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MInt) adherence education (EdMInt) delivered in four sessions
Number of subjects: 336
Study 27282119 — intervention group
Group type: COMPARATOR
Intervention: Education control (EC) delivered at 3-month intervals
Number of subjects: 336
Study 27282119 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MInt) adherence education (EdMInt)
Number of subjects: 336
Study 25316430 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (500 mg, twice daily)
Number of subjects: 232
Study 23177225 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation to the wrist and finger extensor muscles for 1 hour a day over 4 weeks, with splinting for 12 hours a day
Number of subjects: 36
Study 23177225 — intervention group
Group type: COMPARATOR
Intervention: Splinting alone for 12 hours a day over 4 weeks
Number of subjects: 36
Study 20140099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 23
Study 20140099 — intervention group
Group type: COMPARATOR
Intervention: Normal Sleep (RW)
Number of subjects: 23
Study 18839845 — intervention group
Group type: EXPERIMENTAL
Intervention: Kongsap manual phacofragmentation (Group 1)
Number of subjects: 102
Study 18839845 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification (Group 2)
Number of subjects: 102
Study 15784709 — intervention group
Group type: EXPERIMENTAL
Intervention: GH by sc injection six times per week (0.30 mg/kg.wk)
Number of subjects: 154
Study 15784709 — intervention group
Group type: COMPARATOR
Intervention: Control (C), no GH treatment
Number of subjects: 154
Study 11840368 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (5 mg/day, increased to maximum 20 mg/day if non-HDL > 135 mg/dL)
Number of subjects: 57
Study 9803724 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by trained physicians-in-training (residents)
Number of subjects: 1086
Study 9803724 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1086
Study 7699682 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil 5% solution
Number of subjects: 10
Study 7699682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2618585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonathymulin (NT)
Number of subjects: 40
Study 2618585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 363750 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine
Number of subjects: 20
Study 363750 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 20
Study 363750 — intervention group
Group type: COMPARATOR
Intervention: Buffered peroxyborate
Number of subjects: 20
Study 30944142 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine-alcohol for skin preparation before catheter insertion
Number of subjects: 1000
Study 30944142 — intervention group
Group type: COMPARATOR
Intervention: 5% povidone iodine-alcohol for skin preparation before catheter insertion
Number of subjects: 1000
Study 30944142 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of new technologies (catheters designed to minimise blood exposure, zero-reflux needleless connectors, disinfecting caps, flushing PVCs)
Number of subjects: 1000
Study 30944142 — intervention group
Group type: COMPARATOR
Intervention: Standard care without new technologies
Number of subjects: 1000
Study 28683216 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspi-Neb
Number of subjects: 6
Study 28683216 — intervention group
Group type: COMPARATOR
Intervention: Conti-Neb
Number of subjects: 6
Study 27007578 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT-guided surveillance
Number of subjects: 564
Study 27007578 — intervention group
Group type: COMPARATOR
Intervention: Planned neck dissection
Number of subjects: 564
Study 24243886 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg/d
Number of subjects: 9612
Study 24243886 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9612
Study 22502942 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus external-beam radiotherapy
Number of subjects: 264
Study 22502942 — intervention group
Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 264
Study 22502942 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 264
Study 19929371 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for CDI
Number of subjects: 52
Study 17927556 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk reduction counseling that included information, motivational enhancement and behavior skills building
Number of subjects: 319
Study 17927556 — intervention group
Group type: COMPARATOR
Intervention: Brief HIV education counseling
Number of subjects: 319
Study 15991169 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 40
Study 15991169 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 40
Study 12024434 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C meningococcal conjugate vaccine
Number of subjects: 182
Study 9675657 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon treatment with N-acetyl-cysteine
Number of subjects: 25
Study 9675657 — intervention group
Group type: COMPARATOR
Intervention: Interferon treatment without N-acetyl-cysteine
Number of subjects: 25
Study 9675657 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 25
Study 8016036 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg), chewed ad libitum
Number of subjects: 173
Study 8016036 — intervention group
Group type: COMPARATOR
Intervention: No nicotine gum
Number of subjects: 173
Study 2605867 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-hormone combination (adrenaline, cortisol, glucagon)
Number of subjects: 32
Study 2605867 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 32
Study 2605867 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 32
Study 2605867 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 32
Study 7918261 — intervention group
Group type: EXPERIMENTAL
Intervention: FASTPAC
Number of subjects: 44
Study 362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone 17‐valerate 0.1%
Number of subjects: 15
Study 362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.05%
Number of subjects: 15
Study 362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25%
Number of subjects: 15
Study 31400516 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC (Regulation of Cues) program
Number of subjects: 271
Study 31400516 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC combined with BWL
Number of subjects: 271
Study 31400516 — intervention group
Group type: EXPERIMENTAL
Intervention: BWL alone
Number of subjects: 271
Study 31400516 — intervention group
Group type: COMPARATOR
Intervention: Active comparator
Number of subjects: 271
Study 28031318 — intervention group
Group type: EXPERIMENTAL
Intervention: Health checks (up to three checks from 1982 to 1994)
Number of subjects: 17845
Study 28031318 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health checks)
Number of subjects: 17845
Study 27986736 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuling San
Number of subjects: 200
Study 27986736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 25084831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis-derived interphase neutrophils
Number of subjects: 35
Study 25084831 — intervention group
Group type: EXPERIMENTAL
Intervention: Depletion or inhibition of interphase neutrophils in vitro
Number of subjects: 35
Study 25084831 — intervention group
Group type: COMPARATOR
Intervention: Interphase neutrophils in septic shock
Number of subjects: 35
Study 22880820 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg once a day for 14 days
Number of subjects: 31
Study 22880820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 22880820 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 31
Study 19083096 — intervention group
Group type: EXPERIMENTAL
Intervention: Partition-herb moxibustion
Number of subjects: 109
Study 19083096 — intervention group
Group type: COMPARATOR
Intervention: Partition-bran moxibustion
Number of subjects: 109
Study 17346297 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermasilk fabric (sericin-free silk treated with AEGIS AEM5772/5)
Number of subjects: 22
Study 17346297 — intervention group
Group type: COMPARATOR
Intervention: Cotton fabric
Number of subjects: 22
Study 15117904 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 34
Study 15117904 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 34
Study 11181305 — intervention group
Group type: EXPERIMENTAL
Intervention: eptifibatide
Number of subjects: 100
Study 11181305 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study 10328185 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump
Number of subjects: 60
Study 10328185 — intervention group
Group type: COMPARATOR
Intervention: Roller pump
Number of subjects: 60
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy and surgical resection
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection of pulmonary metastases
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with > or = 90% necrosis and postoperative chemotherapy
Number of subjects: 111
Study 8083708 — intervention group
Group type: COMPARATOR
Intervention: Tumor-containing resection margin
Number of subjects: 111
Study 8083708 — intervention group
Group type: COMPARATOR
Intervention: Poor response to preoperative chemotherapy and/or lack of postoperative chemotherapy
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Three or fewer pulmonary nodules
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Four or fewer recurrent pulmonary nodules
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pulmonary metastases
Number of subjects: 111
Study 8083708 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer intervals between primary tumor resection and metastases
Number of subjects: 111
Study 2572182 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 0.11-0.24 mg/kg once daily
Number of subjects: 40
Study 2572182 — intervention group
Group type: COMPARATOR
Intervention: Dexchlorpheniramine 0.10-0.23 mg/kg every 8 hours
Number of subjects: 40
Study 803831 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition with hyperosmolar glucose (10.5 gm nitrogen, 2,340 kilocalories/day)
Number of subjects: 15
Study 803831 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition with hyperosmolar glucose (5.9 gm nitrogen, 1,600 kilocalories/day)
Number of subjects: 15
Study 803831 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nitrogen, 520 kilocalories/day)
Number of subjects: 15
Study 31657262 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based, individualized physiotherapy intervention (6-week duration)
Number of subjects: 13
Study 30361241 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week once-weekly regimen of rifapentine plus isoniazid
Number of subjects: 1284
Study 27473688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for cannabis cessation (1-hour sessions once a week for 16 weeks, in addition to pharmacological treatment)
Number of subjects: 0
Study 27473688 — intervention group
Group type: COMPARATOR
Intervention: Control group (psychoeducation + pharmacological treatment)
Number of subjects: 0
Study 25458786 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (4g/day for 4 weeks)
Number of subjects: 10
Study 22828598 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 51
Study 22828598 — intervention group
Group type: COMPARATOR
Intervention: Centrifugation
Number of subjects: 51
Study 22828598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell salvage
Number of subjects: 51
Study 20435262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery (BSX)
Number of subjects: 452
Study 20435262 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (BAP)
Number of subjects: 452
Study 20435262 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 452
Study 20435262 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline factors
Number of subjects: 452
Study 20435262 — intervention group
Group type: EXPERIMENTAL
Intervention: Weibull predictive model
Number of subjects: 452
Study 18319309 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (E2)
Number of subjects: 55
Study 18319309 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 plus Medroxyprogesterone acetate (MPA)
Number of subjects: 55
Study 18319309 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 55
Study 18319309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 15939408 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (0.5 mg)
Number of subjects: 16
Study 15939408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12902802 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy postpartum
Number of subjects: 497
Study 12902802 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy postpartum
Number of subjects: 497
Study 12902802 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy postpartum
Number of subjects: 497
Study 12902802 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 497
Study 12902802 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) therapy
Number of subjects: 497
Study 12902802 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable therapy
Number of subjects: 497
Study 11082141 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 8785
Study 11082141 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8785
Study 8781906 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical diagnosis in dyspeptic patients (open-access endoscopy group)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: COMPARATOR
Intervention: Clinical diagnosis in dyspeptic patients (empirically managed group)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ulcer dyspepsia (both groups)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical prediction of ulcer (open-access endoscopy group)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: COMPARATOR
Intervention: Clinical prediction of ulcer (empirically managed group)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: EXPERIMENTAL
Intervention: Misclassification of major pathologic lesions as non-ulcer dyspepsia (both groups)
Number of subjects: 1233
Study 8781906 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' provisional diagnoses
Number of subjects: 1233
Study 1516491 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef insulin (B)
Number of subjects: 26
Study 1516491 — intervention group
Group type: COMPARATOR
Intervention: Sulfated beef insulin (SB)
Number of subjects: 26
Study 1516491 — intervention group
Group type: COMPARATOR
Intervention: Pork insulin (P)
Number of subjects: 26
Study 1516491 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (H)
Number of subjects: 26
Study 2981652 — intervention group
Group type: EXPERIMENTAL
Intervention: Metkephamid (50 mg intramuscularly)
Number of subjects: 8
Study 2981652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31502872 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress and Anger Management Program (STAMP)
Number of subjects: 23
Study 31502872 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 23
Study 27043047 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 523
Study 27043047 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 523
Study 24881210 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage II surgery of dental implantation
Number of subjects: 29
Study 22248495 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST
Number of subjects: 19
Study 22248495 — intervention group
Group type: COMPARATOR
Intervention: FED
Number of subjects: 19
Study 20375736 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 28
Study 20375736 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL) control group
Number of subjects: 28
Study 18535684 — intervention group
Group type: EXPERIMENTAL
Intervention: Prestige ST cervical disc prosthesis (Medtronic Sofamor Danek)
Number of subjects: 19
Study 18535684 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 19
Study 16027567 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient counseling with telephone follow-up
Number of subjects: 168
Study 16027567 — intervention group
Group type: COMPARATOR
Intervention: Inpatient counseling
Number of subjects: 168
Study 16027567 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 11818704 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcitriol
Number of subjects: 28
Study 11818704 — intervention group
Group type: EXPERIMENTAL
Intervention: IV calcitriol
Number of subjects: 28
Study 10353012 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphincteroclasy
Number of subjects: 52
Study 7860754 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 binding site antibodies
Number of subjects: 47
Study 7860754 — intervention group
Group type: EXPERIMENTAL
Intervention: Low viral load (defined by two or more negative HIV-1 viral cultures during pregnancy)
Number of subjects: 47
Study 2017111 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydergine/Nifedipine
Number of subjects: 50
Study 2017111 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 50
Study 6127095 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) 0-6 ng kg-1 min-1
Number of subjects: 6
Study 6127095 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) 1 and 2 ng/ml
Number of subjects: 6
Study 6127095 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.04 mg/kg i.v.
Number of subjects: 6
Study 6127095 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 0.2 mg/kg i.v.
Number of subjects: 6
Study 6127095 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 0.2 mg/kg i.v.
Number of subjects: 6
Study 31973713 — intervention group
Group type: EXPERIMENTAL
Intervention: Point OutWords intervention (half an hour, five times a week, for 8 weeks)
Number of subjects: 46